Researchers have found that antigen-specific killer T cells (CD8+ T cells) rapidly expand in the lungs when primed by antigen-presenting lung-resident alveolar macrophages (AMs). This interaction helps protect against viral infection and could form the basis for developing 'cell transplant'-type vaccines in the future.
